• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃及丙型肝炎病毒肝硬化患者活体肝移植术后的细菌感染:一项单中心研究。

Bacterial infections post-living-donor liver transplantation in Egyptian hepatitis C virus-cirrhotic patients: A single-center study.

作者信息

Montasser Mohamed F, Abdelkader Nadia A, Abdelhakam Sara M, Dabbous Hany, Montasser Iman F, Massoud Yasmine M, Abdelmoaty Waleed, Saleh Shereen A, Bahaa Mohamed, Said Hany, El-Meteini Mahmoud

机构信息

Mohamed F Montasser, Nadia A Abdelkader, Sara M Abdelhakam, Hany Dabbous, Iman F Montasser, Yasmine M Massoud, Waleed Abdelmoaty, Department of Tropical Medicine, Faculty of Medicine, Ain Shams University, Cairo 11341, Egypt.

出版信息

World J Hepatol. 2017 Jul 18;9(20):896-904. doi: 10.4254/wjh.v9.i20.896.

DOI:10.4254/wjh.v9.i20.896
PMID:28804572
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5534364/
Abstract

AIM

To determine risk factors, causative organisms and antimicrobial resistance of bacterial infections following living-donor liver transplantation (LDLT) in cirrhotic patients.

METHODS

This prospective study included 45 patients with hepatitis C virus-related end-stage liver disease who underwent LDLT at Ain Shams Center for Organ Transplant, Cairo, Egypt from January 2014 to November 2015. Patients were followed-up for the first 3 mo after LDLT for detection of bacterial infections. All patients were examined for the possible risk factors suggestive of acquiring infection pre-, intra- and post-operatively. Positive cultures based on clinical suspicion and patterns of antimicrobial resistance were identified.

RESULTS

Thirty-three patients (73.3%) suffered from bacterial infections; 21 of them had a single infection episode, and 12 had repeated infection episodes. Bile was the most common site for both single and repeated episodes of infection (28.6% and 27.8%, respectively). The most common isolated organisms were gram-negative bacteria. was the most common organism isolated from both single and repeated infection episodes (19% and 33.3%, respectively), followed by for repeated infections (11.1%), and for single infections (19%). Levofloxacin showed high sensitivity against repeated infection episodes ( = 0.03). , and were multi-drug resistant (MDR). Pre-transplant hepatocellular carcinoma (HCC) and duration of drain insertion (in days) were independent risk factors for the occurrence of repeated infection episodes ( = 0.024).

CONCLUSION

MDR gram-negative bacterial infections are common post-LDLT. Pre-transplant HCC and duration of drain insertion were independent risk factors for the occurrence of repeated infection episodes.

摘要

目的

确定肝硬化患者活体肝移植(LDLT)后细菌感染的危险因素、致病微生物及抗菌药物耐药情况。

方法

这项前瞻性研究纳入了2014年1月至2015年11月在埃及开罗艾因·沙姆斯器官移植中心接受LDLT的45例丙型肝炎病毒相关终末期肝病患者。对患者在LDLT后的前3个月进行随访以检测细菌感染情况。对所有患者术前、术中和术后可能提示感染的危险因素进行检查。根据临床怀疑和抗菌药物耐药模式确定阳性培养结果。

结果

33例患者(73.3%)发生细菌感染;其中21例有单次感染发作,12例有反复感染发作。胆汁是单次和反复感染发作最常见的部位(分别为28.6%和27.8%)。最常见的分离菌为革兰氏阴性菌。 是单次和反复感染发作中最常见的分离菌(分别为19%和33.3%),其次是反复感染中的 (11.1%),单次感染中的 (19%)。左氧氟沙星对反复感染发作显示出高敏感性( = 0.03)。 、 和 为多重耐药(MDR)。移植前肝细胞癌(HCC)和引流管插入时间(天数)是反复感染发作的独立危险因素( = 0.024)。

结论

LDLT后多重耐药革兰氏阴性菌感染常见。移植前HCC和引流管插入时间是反复感染发作的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aca/5534364/e5926a7f787e/WJH-9-896-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aca/5534364/ab6948bac17c/WJH-9-896-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aca/5534364/e5926a7f787e/WJH-9-896-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aca/5534364/ab6948bac17c/WJH-9-896-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aca/5534364/e5926a7f787e/WJH-9-896-g002.jpg

相似文献

1
Bacterial infections post-living-donor liver transplantation in Egyptian hepatitis C virus-cirrhotic patients: A single-center study.埃及丙型肝炎病毒肝硬化患者活体肝移植术后的细菌感染:一项单中心研究。
World J Hepatol. 2017 Jul 18;9(20):896-904. doi: 10.4254/wjh.v9.i20.896.
2
Perioperative bacterial infections in deceased donor and living donor liver transplant recipients.已故供体和活体供体肝移植受者的围手术期细菌感染
J Clin Exp Hepatol. 2012 Mar;2(1):35-41. doi: 10.1016/S0973-6883(12)60081-4. Epub 2012 Apr 12.
3
Infection complications and pattern of bacterial resistance in living-donor liver transplantation: a multicenter epidemiologic study in Egypt.活体肝移植中的感染并发症及细菌耐药模式:埃及的一项多中心流行病学研究
Transplant Proc. 2014 Jun;46(5):1444-7. doi: 10.1016/j.transproceed.2014.02.022.
4
[Clinical analysis of early postoperative pulmonary infection in children after living donor liver transplantation].活体肝移植术后儿童早期肺部感染的临床分析
Zhonghua Er Ke Za Zhi. 2012 Aug;50(8):612-6.
5
The impact of treated bacterial infections within one month before living donor liver transplantation in adults.成人活体肝移植前1个月内接受治疗的细菌感染的影响。
Ann Transplant. 2014 Dec 23;19:674-9. doi: 10.12659/AOT.892095.
6
Pattern of bacterial and fungal infections in the first 3 months after pediatric living donor liver transplantation: an 11-year single-center experience.小儿活体肝移植术后 3 个月内细菌和真菌感染的模式:11 年单中心经验。
Liver Transpl. 2011 Aug;17(8):976-84. doi: 10.1002/lt.22278.
7
Multidrug-resistant gram-negative bacterial infections after liver transplantation - spectrum and risk factors.肝移植术后耐多药革兰氏阴性菌感染:种类和危险因素。
J Infect. 2012 Mar;64(3):299-310. doi: 10.1016/j.jinf.2011.12.005. Epub 2011 Dec 14.
8
The risk factors for early infection in adult living donor liver transplantation recipients.成人活体肝移植受者早期感染的危险因素。
Transplant Proc. 2012 Apr;44(3):784-6. doi: 10.1016/j.transproceed.2012.03.028.
9
Cytomegalovirus infection in living donor liver transplant recipients significantly impacts the early post-transplant outcome: A single center experience.活体供肝移植受者的巨细胞病毒感染对移植后早期结局有显著影响:单中心经验
Transpl Infect Dis. 2018 Aug;20(4):e12905. doi: 10.1111/tid.12905. Epub 2018 May 24.
10
Donor-derived infections among Chinese donation after cardiac death liver recipients.在接受心脏死亡供肝移植的中国患者中,供者源性感染。
World J Gastroenterol. 2017 Aug 21;23(31):5809-5816. doi: 10.3748/wjg.v23.i31.5809.

引用本文的文献

1
Bundle care approach to reduce device associated infections in post-living-donor-liver transplantation in a tertiary care hospital, Egypt.捆绑式护理方案可降低埃及某三级医院活体肝移植术后器械相关感染率
BMC Infect Dis. 2024 Jul 5;24(1):674. doi: 10.1186/s12879-024-09525-4.
2
Multidrug-Resistant Infections in the United Kingdom versus Egypt: Trends and Potential Natural Products Solutions.英国与埃及的多重耐药感染:趋势与潜在的天然产物解决方案
Antibiotics (Basel). 2023 Jan 1;12(1):77. doi: 10.3390/antibiotics12010077.
3
LINC00221 silencing prevents the progression of hepatocellular carcinoma through let-7a-5p-targeted inhibition of MMP11.

本文引用的文献

1
Infection complications and pattern of bacterial resistance in living-donor liver transplantation: a multicenter epidemiologic study in Egypt.活体肝移植中的感染并发症及细菌耐药模式:埃及的一项多中心流行病学研究
Transplant Proc. 2014 Jun;46(5):1444-7. doi: 10.1016/j.transproceed.2014.02.022.
2
Surveillance of bacterial and fungal infections in the postoperative period following liver transplantation: a series from 2005-2011.肝移植术后细菌和真菌感染的监测:2005年至2011年的系列研究
Transplant Proc. 2013 Sep;45(7):2718-21. doi: 10.1016/j.transproceed.2013.08.010.
3
Management of infections in cirrhotic patients: report of a consensus conference.
LINC00221沉默通过let-7a-5p靶向抑制MMP11来阻止肝细胞癌的进展。
Cancer Cell Int. 2021 Apr 9;21(1):202. doi: 10.1186/s12935-021-01819-w.
4
Overexpressed sFRP3 exerts an inhibitory effect on hepatocellular carcinoma via inactivation of the Wnt/β-catenin signaling pathway.过度表达的 sFRP3 通过失活 Wnt/β-连环蛋白信号通路对肝癌发挥抑制作用。
Cancer Gene Ther. 2021 Aug;28(7-8):875-891. doi: 10.1038/s41417-020-0201-z. Epub 2020 Sep 26.
5
The Great ESKAPE: Exploring the Crossroads of Bile and Antibiotic Resistance in Bacterial Pathogens.ESKAPE 之宏大:探索细菌病原体胆汁与抗生素耐药性的交汇点。
Infect Immun. 2020 Sep 18;88(10). doi: 10.1128/IAI.00865-19.
肝硬化患者感染的管理:共识会议报告。
Dig Liver Dis. 2014 Mar;46(3):204-12. doi: 10.1016/j.dld.2013.07.015. Epub 2013 Sep 8.
4
Multidrug-resistant gram-negative bacterial infections after liver transplantation - spectrum and risk factors.肝移植术后耐多药革兰氏阴性菌感染:种类和危险因素。
J Infect. 2012 Mar;64(3):299-310. doi: 10.1016/j.jinf.2011.12.005. Epub 2011 Dec 14.
5
Urinary tract infections in the early posttransplant period after liver transplantation: etiologic agents and their susceptibility.肝移植术后早期的尿路感染:病原体及其敏感性
Transplant Proc. 2011 Oct;43(8):3052-4. doi: 10.1016/j.transproceed.2011.09.003.
6
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.耐多药、广泛耐药和全耐药细菌:获得性耐药的国际专家临时标准定义建议
Clin Microbiol Infect. 2012 Mar;18(3):268-81. doi: 10.1111/j.1469-0691.2011.03570.x. Epub 2011 Jul 27.
7
Infections in liver transplant recipients.肝移植受者的感染
World J Hepatol. 2011 Apr 27;3(4):83-92. doi: 10.4254/wjh.v3.i4.83.
8
Posttransplant bacteremia in adult living donor liver transplant recipients.成人活体肝移植受者移植后菌血症。
Liver Transpl. 2010 Dec;16(12):1379-85. doi: 10.1002/lt.22165.
9
Early bacteremia after solid organ transplantation.实体器官移植后的早期菌血症
Transplant Proc. 2009 Jul-Aug;41(6):2262-4. doi: 10.1016/j.transproceed.2009.06.079.
10
Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients.多重耐药革兰氏阴性杆菌作为肝移植受者血流感染的主要病原菌
Transpl Infect Dis. 2009 Oct;11(5):405-12. doi: 10.1111/j.1399-3062.2009.00421.x. Epub 2009 Jul 22.